<SEC-DOCUMENT>0001607062-19-000084-index.html : 20190222 <SEC-HEADER>0001607062-19-000084.hdr.sgml : 20190222 <ACCEPTANCE-DATETIME>20190222170936 ACCESSION NUMBER: 0001607062-19-000084 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20190215 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190222 DATE AS OF CHANGE: 20190222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 19626614 BUSINESS ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 416-364-2551 MAIL ADDRESS: STREET 1: 10102 USA TODAY WAY CITY: MIRAMAR STATE: FL ZIP: 33025 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>gnbt022219form8k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: gnbt022219form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>ex4_1.htm <DESCRIPTION>EXHIBIT 4.1 <TEXT> Document 2 - file: ex4_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.2 <SEQUENCE>3 <FILENAME>ex4_2.htm <DESCRIPTION>EXHIBIT 4.2 <TEXT> Document 3 - file: ex4_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.3 <SEQUENCE>4 <FILENAME>ex4_3.htm <DESCRIPTION>EXHIBIT 4.3 <TEXT> Document 4 - file: ex4_3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.4 <SEQUENCE>5 <FILENAME>ex4_4.htm <DESCRIPTION>EXHIBIT 4.4 <TEXT> Document 5 - file: ex4_4.htm
</DOCUMENT> </SEC-DOCUMENT>